BIOIX
Price
$42.54
Change
-$2.02 (-4.53%)
Updated
Apr 10 closing price
Net Assets
1.35B
GFACX
Price
$56.51
Change
-$2.32 (-3.94%)
Updated
Apr 10 closing price
Net Assets
271.59B
Ad is loading...

BIOIX vs GFACX

Header iconBIOIX vs GFACX Comparison
Open Charts BIOIX vs GFACXBanner chart's image
Baron Opportunity Instl
Price$42.54
Change-$2.02 (-4.53%)
VolumeN/A
Net Assets1.35B
American Funds Growth Fund of Amer C
Price$56.51
Change-$2.32 (-3.94%)
VolumeN/A
Net Assets271.59B
BIOIX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BIOIX vs. GFACX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOIX is a Buy and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 272B vs. BIOIX (1.35B). BIOIX (0.00) and GFACX (0.00) have matching dividends . BIOIX was incepted earlier than GFACX: BIOIX (16 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than BIOIX (1.05). GFACX is a more actively managed with annual turnover of: 25.00 vs. BIOIX (23.29). GFACX has a lower initial minimum investment than BIOIX: GFACX (250) vs BIOIX (1000000). BIOIX annual gain was more profitable for investors over the last year : 4.38 vs. GFACX (-3.95). BIOIX return over 5 years is better than : 91.00 vs. GFACX (40.74).
BIOIXGFACXBIOIX / GFACX
Total Expense Ratio1.051.3677%
Annual Report Gross Expense Ratio1.051.3677%
Fund Existence16 years24 years-
Gain YTD-11.710-7.732151%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.35B272B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year4.38-3.95-111%
Returns for 3 years29.874.35687%
Returns for 5 years91.0040.74223%
Returns for 10 years125.2838.82323%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DGLY0.03N/A
+15.27%
Digital Ally
BDSX0.570.02
+4.51%
Biodesix
TAP59.951.44
+2.46%
Molson Coors Beverage Company
GYRE7.29-0.51
-6.54%
Gyre Therapeutics
GDRX4.32-0.37
-7.89%
GoodRx Holdings